Relmada Therapeutics, Inc. (RLMD) Earnings Per Share (EPS)
Relmada Therapeutics, Inc. (RLMD) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-06-30 | N/A |
| 2017-06-30 | N/A |
| 2018-06-30 | N/A |
| 2019-06-30 | N/A |
| 2020-12-31 | -$3.81 |
| 2021-12-31 | -$7.16 |
| 2022-12-31 | -$5.30 |
| 2023-12-31 | -$3.28 |
| 2024-12-31 | -$2.65 |
| 2025-12-31 | -$1.45 |
How RLMD compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| IOVA | Iovance Biotherapeutics Inc. | -$1.09 |
| ACHV | Achieve Life Sciences Inc. | -$1.25 |
| ALEC | Alector Inc. | -$1.39 |
| XBIT | XBiotech Inc. | -$1.49 |
| VREX | Varex Imaging Corporation | -$1.70 |
These are five companies in the same sector as RLMD with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Relmada Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("RLMD")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RLMD | $4.54 | -8.10% | 1.81M |
| 3 | ||||
| 4 | ||||
| 5 |